REVB FY 2025 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$27,058

Operating Income

-$9M

Net Income

-$9M

EPS (Diluted)

$-23.95

Cash Flow

Operating Cash Flow

-$8.3B

Free Cash Flow

-$8.3B

Stock-Based Comp.

$595M

Balance Sheet

Total Assets

$11.6B

Total Liabilities

$2.7B

Stockholders' Equity

$8.9B

Cash & Equivalents

$10.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$27,058	-$27,923	+3.1%
Operating Income	-$9M	-$8M	-13.7%
Net Income	-$9M	-$15M	+40.7%